Acne is one of the most common skin conditions seen in preadolescents and adolescents but truncal acne, while common, is typically overlooked and treated secondarily to facial acne. Truncal acne impairs quality of life, independently of facial acne severity. This CE/CME Briefcase emphasizes the importance of addressing the impact truncal acne can have on patients’ quality of life through appropriate diagnosis and treatment, including new treatments options that are specific for truncal acne. Patient cases illustrate key points in diagnosing and assessing the severity of acne, tools to determine the impact of truncal acne on quality of life, treatment regimens that are recommended to treat truncal acne, and strategies to individualize a treatment plan based on response and adverse events.
Case studies with interactive benchmarking
After completing this activity, participants should be better able to:
- Apply screening tools and strategies to assess the grade, severity, and impact of truncal acne in patients
- Develop evidence-based approaches to individualize the treatment of patients with truncal acne
NPs and PAs in dermatology, primary care, and pediatrics
NAPNAP CE Contact Hours Designation
This program is accredited for 0.5 NAPNAP CE contact hours of which 0.5 contain pharmacology (Rx) content, per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines
NP course advisor: Faye Eifert, APRN, FNP-C, UT Southwestern and Children’s Medical Center, Dallas, Texas
Joint Accreditation Statement
In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AAPA Credit Designation
Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until August 15, 2023. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Kristine Kucera, PA-C, UT Southwestern Medical Center, Dallas, Texas
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credits for learning and change.
This activity is supported by an educational grant from Galderma Laboratories, L.P.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of PACE or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Hilary Baldwin, MD: consultant/advisor/speaker: Almirall, Bausch, EPI, Galderma, Journey, Sun.
Kristine Kucera, PA-C: consultant/advisor/speaker: AbbVie, Amgen, Beiersdorf, Bristol-Myers Squibb, Dermavant, Leo, Novartis, Sun, UCB.
None of the members of the Planning Committee, PACE, NAPNAP, and PCE staff have any relevant financial relationships to disclose, except Kristine Kucera, PA-C as noted above.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete evaluation form
The estimated time to complete this activity is 0.50 hours.
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 67%.
Release date: August 16, 2022
Expiration date: August 15, 2023
© 2022 Practicing Clinicians Exchange. All Rights Reserved. PRP5222